Target intelligence / Profile preview

Interferon-induced protein with tetratricopeptide repeats 3 (IFIT3)

Target
IFIT3
Molecular classification
Interferon-stimulated gene product, Intracellular signaling protein, Tetratricopeptide repeat-containing protein (TPR protein), Adapter protein, Other
01

Overview

Interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) is a cytoplasmic protein and key member of the IFIT family, rapidly induced by type I interferon signaling and viral infection. IFIT3 contains tetratricopeptide repeats (TPRs) that mediate protein-protein interactions, allowing the formation of complexes (e.g., with IFIT1 and IFIT2) which are critical for both direct antiviral responses (such as inhibition of viral RNA translation) and indirect amplification of interferon signaling through cytoplasmic sensors, including STING and MAVS pathways. IFIT3 has no known enzymatic activity but acts as a multifaceted adapter in innate immunity, controlling cell proliferation, apoptosis, and inflammatory signaling, and is implicated in infection control, tumor immunity, and cellular stress responses. Emerging research highlights its clinical potential as a biomarker and possible therapeutic target, especially in cancer and viral diseases, although direct pharmacological targeting is not established as of the latest literature.

Other names
IFIT3CIG-49IFI60IFIT4ISG60IFIT-3IFI-60KIFIT-4P60RIG-Gcig41IRG2CIG49GARG-49ISG-60Interferon-induced 60 kDa proteinInterferon-induced protein with tetratricopeptide repeats 4Retinoic acid-induced gene G protein
02

Mechanism of action

Not directly drugged; mechanisms involve indirect activation or inhibition of interferon signaling or modulation of antiviral/immune pathways. Acts as part of IFIT complexes to inhibit translation of non-self/viral RNAs. Bridges interactions between MAVS and TBK1, leading to interferon response activation.

03

Biological functions

Antiviral innate immunitySignal transductionCell proliferationApoptosisImmunomodulationRegulation of translation/translation inhibitionCell differentiation
04

Disease associations

Infection, especially viralCancerInflammationOther (potential biomarker for disease diagnosis/therapy)
05

Safety considerations

Overexpression linked to unwanted inflammation or altered immune responsesPossible involvement in tumor immune evasion via modulation of immune checkpointsPotential off-target or systemic effects if therapeutically targeted
06

Biomarkers

M1 macrophage markerDisease biomarker for antiviral status and immune response activity

Beyond the preview

Go deeper on Interferon-induced protein with tetratricopeptide repeats 3 (IFIT3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Interferon-induced protein with tetratricopeptide repeats 3 (IFIT3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call